Tirzepatide vs Semaglutide for Weight Loss: Which Is Right for You?

Key Takeaways

Quick Verdict	Tirzepatide averaged 20.2% weight loss versus 13.7% for Semaglutide in SURMOUNT-5. But, a prescriber decides what’s better for you.
Ideal Candidate	Adults with BMI 30 or higher, or 27 or higher with a weight related condition.
Timeline	Dose steps at least 4 weeks apart, SURMOUNT-5 results at 72 weeks, ongoing treatment.
Provider Note	I screen your history first and set every dose.

Tirzepatide led the only head to head weight loss trial. In SURMOUNT-5, adults with obesity and no Type-2 diabetes lost an average of 20.2% of body weight on Tirzepatide and 13.7% on Semaglutide over 72 weeks. Those averages come from the treatment regimen analysis, and averages cannot decide Tirzepatide vs Semaglutide for weight loss for one person. Only a qualified prescriber can determine which drug will help you.

I take that gap seriously. Your health history and stomach tolerance still shape which drug suits you.

Tirzepatide vs. Semaglutide for Weight Loss at a Glance

Common Queries	Tirzepatide	Semaglutide
How it works	Activates GIP and GLP-1 receptors	Activates GLP-1 receptors
FDA approved weight brands	Zepbound, from Eli Lilly	Wegovy, from Novo Nordisk
Format, as of September 2026	Weekly injection	Weekly injection, or a daily Wegovy tablet
Starting dose	2.5 mg once weekly	0.25 mg once weekly as an injection, or 1.5 mg once daily as a tablet
Maintenance doses for weight	5, 10, or 15 mg once weekly	1.7 or 2.4 mg once weekly, with 2.4 mg recommended. Up to 7.2 mg once weekly for some adults. 25 mg once daily as a tablet
SURMOUNT-5 average result in 751 adults with obesity and no Type-2 diabetes over 72 weeks, treatment regimen analysis	20.2% of body weight	13.7% of body weight
Most common side effects	Nausea, diarrhea, vomiting, constipation	Nausea, diarrhea, vomiting, constipation

Semaglutide vs Tirzepatide for Weight Loss: How Each Drug Works

Semaglutide, by Novo Nordisk, copies one gut hormone called GLP-1, which helps regulate appetite and slows how fast your stomach empties. Tirzepatide, made by Eli Lilly, copies GIP and GLP-1, so researchers call it a dual agonist, and nonclinical studies suggest GIP adds to appetite control.

Think of appetite as a hallway with two dimmer switches. Semaglutide turns one, and Tirzepatide turns both.

That dual action shapes Tirzepatide vs Semaglutide for weight loss. Only Wegovy from Novo Nordisk and Zepbound from Eli Lilly carry weight management labels. Zepbound is a weekly injection, and Wegovy also comes as a daily tablet.

What Does the Research Say About Tirzepatide vs Semaglutide for Weight Loss?

SURMOUNT-5 is the only head to head trial of Tirzepatide vs Semaglutide for weight loss, and it enrolled 751 adults with obesity and no Type-2 diabetes. Over 72 weeks, adults lost an average of 20.2% of body weight on Tirzepatide and 13.7% on Semaglutide, using the treatment regimen analysis.

The Head to Head Trial

Eli Lilly funded this open label trial, where everyone knew who took which drug. Researchers did not test semaglutide 7.2 mg.

Tirzepatide vs Semaglutide, which is better for weight loss? On average, more people taking tirzepatide reached every weight-loss goal, from 10% to 25%. Averages hide a range, so some adults lose more and some lose less.

What Changed in 2026

The FDA approved Wegovy HD, a 7.2 mg Semaglutide injection, on March 19, 2026. It fits adults who tolerated 2.4 mg for at least 4 weeks and need more weight reduction.

In STEP UP, 1,407 adults with obesity and no diabetes lost an average of 18.7% on 7.2 mg and 15.6% on 2.4 mg over 72 weeks. That trial used the treatment policy analysis, and SURMOUNT-5 used a comparable one, so the two figures sit closer than headlines suggest.

What Happens if You Stop

In SURMOUNT-4, adults with obesity or higher weight lost an average of 20.9% over 36 weeks of Tirzepatide. Those who then switched to placebo regained an average of 14.0% by week 88, while those who continued lost another 5.5%.

Tirzepatide vs Semaglutide Dosage for Weight Loss: How Titration Works

Zepbound starts at 2.5 mg once weekly, and Wegovy injection starts at 0.25 mg once weekly. Both the Zepbound label and the Wegovy label raise the dose in steps at least 4 weeks apart to reduce stomach side effects. That is why Tirzepatide vs Semaglutide dosage for weight loss looks like a slow staircase. Slow on purpose.

The Zepbound label tops out at 15 mg weekly. Wegovy injection usually holds at 2.4 mg, and 7.2 mg follows only after at least 4 weeks on 2.4 mg when more weight reduction is indicated.

You don’t need to worry about choosing the dose. Your prescriber will set it for you.

What Are the Side Effects and Safety Risks of Each?

Most side-effects on Zepbound and Wegovy are stomach related, and they cluster while the dose rises, led by nausea and diarrhea along with vomiting and constipation. Both labels also carry a boxed warning about Thyroid C-cell tumors found in rodents, and whether that risk applies to humans is unknown.

Both labels list a personal or family history of medullary thyroid carcinoma or MEN-2 as a contraindication. They also warn about pancreatitis, gallbladder disease, kidney harm from dehydration, and severe allergic reactions.

In SURMOUNT-5, stomach side-effects ended treatment for 2.7% of adults on tirzepatide. The rate was 5.6% on semaglutide over 72 weeks. That gap does not make either drug 100% safer overall.

On Zepbound, oral birth control can lose effectiveness. The label calls for a nonoral or barrier method for 4 weeks after starting and after each dose increase. Both labels call for stopping when pregnancy is recognized, and breastfeeding belongs in your consultation. Seek urgent care for severe stomach pain, or for face or throat swelling with trouble breathing.

Who Should Choose Tirzepatide vs Semaglutide for Weight Loss?

No single drug fits every adult with obesity, so a qualified prescriber weighs your history and goals before choosing between Zepbound and Wegovy. Both labels cover adults with obesity, or with a weight related condition, and pair the drug with a reduced calorie diet and more physical activity. Several factors guide that call.

Your stomach sets the pace at every dose step, and a prescriber can slow the increases. The Zepbound label covers moderate to severe obstructive sleep apnea in adults with obesity. The Wegovy label covers reducing the risk of major cardiovascular events in adults with established cardiovascular disease.

Format and coverage matter too. Wegovy also comes as a daily tablet, and coverage differs by plan, so check with your insurer before you weigh Semaglutide vs Tirzepatide for weight loss.

Switching is a prescriber decision. No universal dose conversion exists between the two drugs. A consultation with a qualified prescriber determines candidacy.

Are You a Candidate?

A Good Candidate if…	Talk to a Prescriber First if…
You are an adult with obesity, or with higher weight and at least one weight related condition, as studied in the trials	You or a close relative had Medullary Thyroid Carcinoma or MEN-2
You have moderate to severe obstructive sleep apnea and obesity, per the Zepbound label	You are pregnant or planning a pregnancy
You have established cardiovascular disease with obesity or higher weight, per the Wegovy label	You are breastfeeding
You want a weekly injection, or a daily tablet with Wegovy	You have had pancreatitis or gallbladder disease
You want medical support alongside a reduced calorie diet and more physical activity	You use insulin or a sulfonylurea
You want a clear plan for follow ups and dose steps	You have a severe stomach or digestive condition
You want to compare coverage and access before you decide	You have surgery or a procedure with anesthesia planned
A consultation with a qualified prescriber determines candidacy.	A consultation with a qualified prescriber determines candidacy.

What Happens at a GLP-1 Consultation and After You Start?

A virtual GLP-1 consultation with Serenity Medical Aesthetics starts with your medical history and current medications, then covers your weight history and pregnancy plans before anyone prescribes anything. After you start, follow ups match each dose step, and a prescriber reviews side effects and progress with you at every visit. Preparation helps.

Bring a current medication list and your health history. Share any pregnancy plans too.

Results vary from person to person, and every trial figure in this article is an average, not a promise. The labels space dose increases at least 4 weeks apart for the weekly injections. Expect follow ups at each step.

Phase	When	What happens
Before	Before you book	Gather your medication list, health history, family history of thyroid cancer, and pregnancy plans. Check coverage with your insurer.
First visit	Day of consultation	A qualified prescriber reviews history, medications, and goals, screens for contraindications, and records baseline weight and blood pressure.
First 4 weeks	Weeks 1 to 4	Starting dose only, per the label. Report side effects to your prescriber.
Every 4 weeks	Each dose step for weekly injections, or every 30 days for Wegovy tablets	Your prescriber reviews tolerance and progress and decides whether to raise the dose.
Ongoing	After you reach a maintenance dose	Your prescriber reviews progress, side effects, and the long-term or stopping plan.

Book Your GLP-1 Consultation Now!

If Tirzepatide vs Semaglutide for weight loss still feels confusing, a qualified prescriber can review your history with you and answer every question you bring to the visit. Our Pasadena practice connects adults with board certified prescribers through partner Metamorfx Health, and the medications we offer are both FDA approved brands and compounded options.

Schedule a weight loss consultation with Serenity Medical Aesthetics in Pasadena, CA. No pressure. Just clear answers and a plan built around you.

Frequently Asked Questions

Which Is Better for Weight Loss, Tirzepatide or Semaglutide?

Tirzepatide led the only head to head trial on average. Still, Tirzepatide vs Semaglutide for weight loss depends on your history, goals, and stomach tolerance, so a prescriber decides.

Can You Switch From Semaglutide to Tirzepatide?

A prescriber decides whether to switch. No universal dose conversion exists between the two drugs, so never switch on your own. Bring your medication list to that visit.

How Long Do You Stay on Tirzepatide or Semaglutide?

The labels cover long term weight management. In SURMOUNT-4, adults who switched to placebo after 36 weeks of tirzepatide regained an average of 14.0% by week 88.

Semaglutide vs. Tirzepatide for Weight Loss: Which Has More Side Effects?

Both cause mostly stomach side effects during dose increases. In SURMOUNT-5, 2.7% stopped tirzepatide and 5.6% stopped semaglutide because of stomach effects, and neither drug is proven safer overall.

Are Compounded Tirzepatide and Semaglutide the Same as Zepbound and Wegovy?

No. Compounded drugs are not FDA approved, and the FDA does not verify their safety or effectiveness. Zepbound and Wegovy are the FDA approved brands.

MEDICAL DISCLAIMER: This blog post is written for educational and informational purposes only and does not constitute medical advice. Individual results vary. Always consult a qualified medical professional before starting, stopping, or changing any weight loss medication. Serenity Medical Aesthetics is a licensed medical practice in Pasadena, CA.